2 results
Approved WMOCompleted
To investigate whether ticagrelor increases adenosine receptor stimulation in humans in vivo by ENT inhibition.
Approved WMOCompleted
Ticagrelor, at steady state (i.e. after 30 days), will be associated to an improved endothelial function as compared to clopidogrel or prasugrel.